These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 10511591)

  • 1. Diagnostic testing following fecal occult blood screening in the elderly.
    Lurie JD; Welch HG
    J Natl Cancer Inst; 1999 Oct; 91(19):1641-6. PubMed ID: 10511591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening result.
    Baig N; Myers RE; Turner BJ; Grana J; Rothermel T; Schlackman N; Weinberg DS
    Am J Gastroenterol; 2003 Sep; 98(9):2078-81. PubMed ID: 14499791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of follow-up after fecal occult blood testing in older adults: inappropriate screening or failure to follow up?
    Carlson CM; Kirby KA; Casadei MA; Partin MR; Kistler CE; Walter LC
    Arch Intern Med; 2011 Feb; 171(3):249-56. PubMed ID: 20937917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic variation among Medicare beneficiaries in the use of colorectal carcinoma screening procedures.
    Cooper GS; Koroukian SM
    Am J Gastroenterol; 2004 Aug; 99(8):1544-50. PubMed ID: 15307875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national survey of primary care physicians' methods for screening for fecal occult blood.
    Nadel MR; Shapiro JA; Klabunde CN; Seeff LC; Uhler R; Smith RA; Ransohoff DF
    Ann Intern Med; 2005 Jan; 142(2):86-94. PubMed ID: 15657156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of colorectal cancer screening in diverse primary care practices.
    Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
    BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
    Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal occult blood test use by Kansas medicare beneficiaries.
    Engelman KK; Ellerbeck EF; Ahluwalia JS; Nazir N; Velasco A
    Prev Med; 2001 Dec; 33(6):622-6. PubMed ID: 11716659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening: a community case-control study of proctosigmoidoscopy, barium enema radiography, and fecal occult blood test efficacy.
    Scheitel SM; Ahlquist DA; Wollan PC; Hagen PT; Silverstein MD
    Mayo Clin Proc; 1999 Dec; 74(12):1207-13. PubMed ID: 10593348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of costs and effects of screening for colorectal cancer in the United States.
    Byers T; Gorsky R
    Cancer; 1992 Sep; 70(5 Suppl):1288-95. PubMed ID: 1387342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent demographic differences in colorectal cancer screening utilization despite Medicare reimbursement.
    Ko CW; Kreuter W; Baldwin LM
    BMC Gastroenterol; 2005 Mar; 5():10. PubMed ID: 15755323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for colorectal cancer: the cost to find an advanced adenoma.
    McGrath JS; Ponich TP; Gregor JC
    Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in the diagnostic evaluation of a positive fecal occult blood test in an integrated health care organization.
    Miglioretti DL; Rutter CM; Bradford SC; Zauber AG; Kessler LG; Feuer EJ; Grossman DC
    Med Care; 2008 Sep; 46(9 Suppl 1):S91-6. PubMed ID: 18725839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
    Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of faecal occult blood tests requested outside the UK National Bowel Cancer Screening Programme.
    McDonald R; Tomlins A; Smith S; Harmston C
    J Clin Pathol; 2013 Apr; 66(4):330-4. PubMed ID: 23288919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Medicare coverage on use of invasive colorectal cancer screening tests.
    Ko CW; Kreuter W; Baldwin LM
    Arch Intern Med; 2002 Dec 9-23; 162(22):2581-6. PubMed ID: 12456230
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.